Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

A Longitudinal Hepatitis B Vaccine Cohort Demonstrates Long-lasting Hepatitis B Virus (HBV) Cellular Immunity Despite Loss of Antibody Against HBV Surface Antigen.

Simons BC, Spradling PR, Bruden DJ, Zanis C, Case S, Choromanski TL, Apodaca M, Brogdon HD, Dwyer G, Snowball M, Negus S, Bruce MG, Morishima C, Knall C, McMahon BJ.

J Infect Dis. 2016 Jul 15;214(2):273-80. doi: 10.1093/infdis/jiw142. Epub 2016 Apr 7.

2.

Antibody Levels and Protection After Hepatitis B Vaccine: Results of a 30-Year Follow-up Study and Response to a Booster Dose.

Bruce MG, Bruden D, Hurlburt D, Zanis C, Thompson G, Rea L, Toomey M, Townshend-Bulson L, Rudolph K, Bulkow L, Spradling PR, Baum R, Hennessy T, McMahon BJ.

J Infect Dis. 2016 Jul 1;214(1):16-22. doi: 10.1093/infdis/jiv748. Epub 2016 Jan 21.

PMID:
26802139
3.

The effect of Helicobacter pylori infection on iron stores and iron deficiency in urban Alaska Native adults.

Miernyk K, Bruden D, Zanis C, McMahon B, Sacco F, Hennessy T, Parkinson A, Bruce M.

Helicobacter. 2013 Jun;18(3):222-8. doi: 10.1111/hel.12036. Epub 2013 Jan 15.

4.

Repeat revaccination with 23-valent pneumococcal polysaccharide vaccine among adults aged 55-74 years living in Alaska: no evidence of hyporesponsiveness.

Hammitt LL, Bulkow LR, Singleton RJ, Nuorti JP, Hummel KB, Miernyk KM, Zanis C, Whaley M, Romero-Steiner S, Butler JC, Rudolph K, Hennessy TW.

Vaccine. 2011 Mar 9;29(12):2287-95. doi: 10.1016/j.vaccine.2011.01.029. Epub 2011 Jan 19.

PMID:
21255685
5.

Antibody levels and protection after hepatitis B vaccine: results of a 22-year follow-up study and response to a booster dose.

McMahon BJ, Dentinger CM, Bruden D, Zanis C, Peters H, Hurlburt D, Bulkow L, Fiore AE, Bell BP, Hennessy TW.

J Infect Dis. 2009 Nov 1;200(9):1390-6. doi: 10.1086/606119.

PMID:
19785526
6.

Persistence of antibody to hepatitis A virus 10 years after vaccination among children and adults.

Hammitt LL, Bulkow L, Hennessy TW, Zanis C, Snowball M, Williams JL, Bell BP, McMahon BJ.

J Infect Dis. 2008 Dec 15;198(12):1776-82. doi: 10.1086/593335.

PMID:
18976095
7.

Hepatitis B immunity in children vaccinated with recombinant hepatitis B vaccine beginning at birth: a follow-up study at 15 years.

Hammitt LL, Hennessy TW, Fiore AE, Zanis C, Hummel KB, Dunaway E, Bulkow L, McMahon BJ.

Vaccine. 2007 Sep 28;25(39-40):6958-64. Epub 2007 Jul 17.

PMID:
17714836
8.

Relationship between IgE and specific aeroallergen sensitivity in Alaskan native children.

Redding GJ, Singleton RJ, DeMain J, Bulkow LR, Martinez P, Lewis TC, Zanis C, Butler JC.

Ann Allergy Asthma Immunol. 2006 Aug;97(2):209-15.

PMID:
16937753
9.

Antibody levels and protection after hepatitis B vaccination: results of a 15-year follow-up.

McMahon BJ, Bruden DL, Petersen KM, Bulkow LR, Parkinson AJ, Nainan O, Khristova M, Zanis C, Peters H, Margolis HS.

Ann Intern Med. 2005 Mar 1;142(5):333-41.

PMID:
15738452
10.

Duration of hepatitis B immunity in low risk children receiving hepatitis B vaccinations from birth.

Petersen KM, Bulkow LR, McMahon BJ, Zanis C, Getty M, Peters H, Parkinson AJ.

Pediatr Infect Dis J. 2004 Jul;23(7):650-5.

PMID:
15247604
11.

Hepatocellular carcinoma not related to hepatitis B virus infection among Alaska natives.

Chung YH, Di Bisceglie AM, McMahon BJ, Lanier AP, Harpster A, Alter MJ, Parkinson AJ, Zanis C.

Int J Circumpolar Health. 1999 Jul;58(3):208-13.

PMID:
10528471
12.

Protection provided by hepatitis B vaccine in a Yupik Eskimo population--results of a 10-year study.

Wainwright RB, Bulkow LR, Parkinson AJ, Zanis C, McMahon BJ.

J Infect Dis. 1997 Mar;175(3):674-7.

PMID:
9041341

Supplemental Content

Loading ...
Support Center